All Articles

With 100,000 clinicians in 15 months, Marit Health is using AI and peer data to tackle physician burnout, reshaping how doctors manage their careers.

Contango Silver & Gold accelerates work on three key projects, but its most critical challenge may not be in the ground, but in navigating markets and regulations.

A new model for AI data centers is emerging in Texas, using smaller, faster projects to sidestep the power grid bottlenecks that plague hyperscale giants.

Great Hill Partners' investment in Woof Gang signals a new era for the pet care industry, fueling a franchise powerhouse in a multi-billion dollar market.

The B2B tech world is shifting. Generalist PR is out, and deep specialization is in. How one agency's growth reveals the future of tech communication.

With its key project stalled, Lithium Ionic's appointment of a regulatory expert is a calculated move to navigate Brazil's complex mining landscape.

Bacardi now wholly owns Teeling Irish Whiskey. This isn't just another buyout; it's a new model for how industry giants can acquire and amplify craft soul.

A new, fast-acting neurotoxin with a two-week lifespan just hit the market. Allergan's Boey® aims to capture hesitant consumers with a low-commitment 'trial run'.

A new KKR-backed platform is betting big on turning game-day venues into year-round mega-districts, starting in Knoxville. It’s a multi-billion-dollar playbook.

At the world's largest naval exercise, Havoc's autonomous vessels are conducting a groundbreaking multinational resupply mission, heralding a new era.

Soleo Health's repeat URAC award isn't just a corporate win. It signals a crucial shift where data-driven quality becomes the bedrock of a resilient system.

An FDA fast-track for a devastating brain disease drug is a beacon of hope for patients and a major validation of Alphabet's long-term biotech strategy.

A new partnership between AGEPHA Pharma and Close-Up Intl reveals how AI is not just a buzzword, but a critical tool for getting vital medicines to patients.

Denodo's 'One to Watch' status in Snowflake's latest report signals a new era where autonomous AI agents, fueled by governed data, redefine marketing.

Platinum Equity's acquisition of Tangent Technologies isn't just a deal; it's a bet on a future where recycled plastic replaces traditional lumber.

Amylyx reveals positive initial safety data for its new ALS drug, AMX0114, a critical step as the firm aims to rebuild after the Relyvrio withdrawal.

After a record stock plunge, Accenture's massive share buyback isn't just a financial defense—it's a defiant declaration of its AI-fueled future.

Tiffany Moon’s award celebrates compassion, but it also highlights a critical strategy for solving the home care crisis: investing in people.

A new platform, Remora, launches to unify the fragmented options workflow, but its true innovation is running natively inside AI assistants like Claude.

As Ryder prepares its Q2 report, investors watch closely. Will its tech bets pay off amid rising freight demand and persistent market disruption?